Announces Appointment of New Non-Executive Director
The sectors have ranged from IT and communications through environmental and finance to PFI in hospitals and Education.
Kevin has a proven track record as a change agent and has an excellent, mature network of business leaders, contacts and partners. Recent successful business engagements include SpinVox, Dennis Publishing, Carteme, Phones 4 U, PRS and PTS Consulting.
He is a Director and Shareholder at European American Capital, Carteme, Applied Cytometry, Plasma Europe and at Waterbridge Capital
Kevin is passionate about value creation, often at a consumer level, usually delivered via B2B relationships.
Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.
Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.
WESTHOUSE MEDICAL SERVICES PLC
About Westhouse Medical Services Plc
Westhouse Medical (FRA:5WM) consists of two wholly-owned subsidiaries: Westhouse Medical Ltd and Westhouse Medical Devices Ltd. Westhouse is expanding rapidly through the acquisition and expansion of primary healthcare businesses within Europe and North America". Westhouse Medical Services Plc has a dynamic range of Medical Services and Devices providing cutting edge innovation in the medical sectors such as a non-invasive
Test for Breast Cancer and a patented procedure to treat glaucoma. www.westhousemedical.com
Westhouse Medical Services Plc
Wedgewood Investment Group LLC.